Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Alder Biopharma Cmn (ALDR)

19.70 0 (+0.00%)

6/26/2017  12:57pm

Open:

19.80

Pre. Close:

19.70

High:

19.97

Low:

19.00

Volume:

300,535

Market Cap:

993.08M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

20.04 - 20.66

20.66 - 21.28

Low:

18.01 - 18.3

18.3 - 18.6

Close:

19.2 - 20.01

20.01 - 20.82

Technical analysis  (as of: 2017-06-26 12:51:34 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 23.36     One year: 27.28

Support:

Support1: 16.97    Support2: 15.10

Resistance:

Resistance1: 20.00    Resistance2: 23.36

Pivot:

17.88

Moving Averages:

MA(5): 19.32     MA(20): 17.49

MA(100): 20.51     MA(250): 24.56

MACD:

MACD(12,26): 0.26     Signal(12,26,9): -0.16

%K %D:

%K(14,3): 89.26     %D(3): 86.44

RSI:

RSI(14): 59.74

52-Week:

High: 36.48  Low: 15.10  Change(%): -20.8

Average Vol(K):

3-Month: 38803  10-Days 885

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
ALDR has closed below upper band by 17.6%. Bollinger Bands are 17.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 03 May 2017 17:15:00 GMT
Why Alder Biopharmaceuticals Is Down - And What To Do About It

Wed, 21 Jun 2017 10:41:15 GMT
Today Analysts Focus on Kimberly-Clark Corporation (KMB), Alder ...

Mon, 29 May 2017 13:22:57 GMT
Is It Time to go for Alder Biopharmaceuticals, Inc. (ALDR), Coherus ...

Thu, 01 Jun 2017 21:30:06 GMT
Alder BioPharmaceuticals Inc. (ALDR) Soars 10.39% on June 01

Mon, 26 Jun 2017 12:00:00 GMT
$-1.71 EPS Expected for Alder Biopharmaceuticals (ALDR); 2 Analysts Are ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

50.41

Shares Float (M)

44.27

% Held by Insiders

33.94

% Held by Institutions

73.80

Shares Short (K)

8070

Shares Short Prior Month (K)

8540

Stock Financials

EPS

-4.460

EPS Est. Current Year

-6.440

EPS Est. Next Year

-4.010

EPS Est. Next Quarter

-1.450

Forward EPS

-4.014

Book Value (p.s.)

5.710

PEG Ratio

-0.11

Profit Margin

Operating Margin

-199899.13

Return on Assets (ttm)

-40.9

Return on Equity (ttm)

-69.2

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-4.438

Qtrly Earnings Growth

Operating Cash Flow (M)

-193.80

Levered Free Cash Flow (M)

-118.54

FoxReading.com

Valuation

P/E

-4.35

P/E Growth Ratio

-0.02

P/BV

3.40

P/S

P/CF

-5.05

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.